Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) Stock Information | RedChip

Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) Listen to this Section


$0.86
+0.0120 ( +1.41% ) 149.3K

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Market Data


Open


$0.86

Previous close


$0.85

Volume


149.3K

Market cap


$4.15M

Day range


$0.79 - $1.03

52 week range


$0.46 - $9.50

Insider Ownership Transactions

Total Amount Purchased: -389,500.00 | $ -335,359.50

Date Type Amount Purchased Purchaser
2024-07-10 Sale -2500.00 Field Katharyn
2024-07-09 Sale -2500.00 Dhaliwal Jatinder
2024-07-09 Sale -2500.00 Herman Gary L
2024-01-31 Sale -25000.00 Sendrow Jerrold
2024-01-31 Sale -25000.00 Dubin Michael F
2024-01-31 Sale -125000.00 Bruce Gerald W
2024-01-31 Sale -25000.00 Jambulingam Thani
2024-01-31 Sale -112000.00 Shah Vinay
2024-01-31 Sale -25000.00 Singh Vanila
2024-01-31 Sale -45000.00 Floyd Eric

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 13, 2024
10-q Quarterly Reports 57 Aug 12, 2024
8-k 8K-related 15 Jul 30, 2024
8-k 8K-related 13 Jul 26, 2024
8-k 8K-related 15 Jul 24, 2024
3 Insider transactions 2 Jul 15, 2024
8-k 8K-related 13 Jul 15, 2024
3 Insider transactions 2 Jul 10, 2024
8-k 8K-related 15 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.